Delivery Order SPE2DB22D9311-SPE2DB24FP6XW

Award Date 6/25/24
Potential Completion Date 7/17/24
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,805.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Kyleena 19.5 mg intrauterine contraceptive systems and has an ultimate completion date of April 12, 2024. DMS Pharmaceutical Group holds a separate indefinite delivery contract (IDV) with DLA valued up to $4,999,999 through 2025, enabling the agency to issue...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,195.76, is for the delivery of the Kyleena 19.5 mg intrauterine system, a long-acting reversible contraceptive. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,611.58 firm fixed-price contract is for the delivery of the contraceptive device Kyleena 19.5mg. This contract is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to place delivery orders for a wide range of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,859.07 contract is for the delivery of Kyleena 19.5 mg intrauterine systems, a contraceptive device, to support the medical supply needs of military healthcare facilities. The contract has an ultimate completion date of February 25, 2025. DMS Pharmaceutical Group Inc. holds a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,718.30 contract is for the supply of the contraceptive device Kyleena 19.5 mg systems. This delivery order is placed under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to issue orders for a comprehensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,629.64 award is for the supply of the Kyleena 19.5 MG contraceptive system. The delivery order is part of DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract with the DLA, which allows the agency to issue firm fixed-price orders for a comprehensive range of...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $2,407.68 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, which has a performance period through May 17, 2024, is to provide the DLA's Medical Supply Chain division with a Kyleena 19.5 mg intrauterine system. This delivery order is part of a larger $499,999,999 indefinite delivery contract (SPE2DB) held by DMS...
This $11,677.20 firm fixed-price delivery order was awarded by the Defense Logistics Agency, a component of the Department of Defense, to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the supply of the contraceptive device KYLEENA 19.5 MG SYSTEMS to support the medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract, SPE2DB, which enables the Defense Logistics...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,009.65 contract is for the supply of the contraceptive device KYLEENA 19.5 MG SYSTEMS to support the medical needs of military healthcare facilities. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,788.80 firm fixed-price contract is for the delivery of 4,561,740,670 units of the contraceptive device Kyleena 19.5 mg. This delivery order is issued under a larger five-year, $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, which enables the agency to...
  • SPE2DB22D9311
    Indefinite Delivery Contract
  • SPE2DB22D9311-SPE2DB24FP6XW
    Delivery Order

This is a $3,009.65 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Kyleena 19.5 mg intrauterine contraceptive systems to support the medical needs of military healthcare facilities. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a comprehensive range of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its small business status to secure direct federal awards across various medical product categories.

Generated 5/17/25, 9:57 AM